Sort by
Refine Your Search
-
, and scholarly activities. In partnership with Northeastern University, Intellia Therapeutics is offering a two-year Health economics and outcomes research (HEOR) fellowship, based in Cambridge, MA
-
to clinical research, health economics and outcomes research, and real-world evidence. The Fellow will support strategic dissemination of data across a wide range of channels and lead diverse projects
-
Diseases (GRD) is a Chiesi Group’s business unit established in February 2020 and focused on research, development and commercialization of treatments and patient support services for rare and ultra-rare
-
, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of
-
-pharmaceutical company that focuses on innovation, where a long tradition in the field of personal wellness goes hand-in-hand with a commitment to research and development to meet unsatisfied therapeutic needs
-
, join us at AstraZeneca Cardiovascular, Renal or Metabolism (CVRM) regulatory affairs to get involved in the global regulatory strategies and support the research, development and commercialization of our
-
or supporting grant review processes • Supporting clinical development activities, such as protocol development, contract research organization engagement, medical writing for submissions, and site qualification
-
the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research
-
therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust
-
fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of